Spectrum Pharmaceuticals, Inc. Purchase Agreements
11 Contracts & Agreements
- Securities Purchase Agreement, dated January 3, 2022, between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceutical Co., Ltd (Filed With SEC on January 6, 2022)
- Asset Purchase Agreement, dated January 17, 2019, by and among Spectrum Pharmaceuticals, Inc., Acrotech Biopharma LLC and Aurobindo Pharma USA, Inc (Filed With SEC on January 17, 2019)
- CONFIDENTIAL LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF JANUARY 23, 2012 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND BAYER PHARMA AG (Filed With SEC on May 4, 2017)
- AMENDMENT TO LICENSE AND ASSET PURCHASE AGREEMENT (Filed With SEC on May 6, 2016)
- LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF NOVEMBER 16, 2015 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED (Filed With SEC on March 14, 2016)
- CONFIDENTIAL LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF JANUARY 23, 2012 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND BAYER PHARMA AG TABLE OF CONTENTS (Filed With SEC on April 27, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 2, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 18, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 28, 2009)
- PURCHASE AND FORMATION AGREEMENT (Filed With SEC on December 19, 2008)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 23, 2002)